Funds › Candriam S.C.A.
Candriam S.C.A.
13F for Q3 2026, filed Nov 3, 2026. 630 positions worth $22.5B.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what are the biggest new, added, trimmed and exited positions of Candriam S.C.A. in the latest 13F quarter?
Using 13F.ai, how has Candriam S.C.A.'s portfolio concentration changed over the last four quarters?
Using 13F.ai, which of Candriam S.C.A.'s top holdings have also been bought by insiders recently?
Connect your AI · Plans and the 7-day free trial (card required)
Holdings, Q3 2026
Largest first. Common shares only; puts and calls are under All positions.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | NVDA NVIDIA Corporation | 6.79M | $1.6B | 6.9% | -3.6% | 13F ↗ |
| 2 | MSFT Microsoft Corporation | 2.56M | $1.3B | 5.9% | +1.7% | 13F ↗ |
| 3 | AAPL Apple Inc. | 3.55M | $1.2B | 5.3% | -2.4% | 13F ↗ |
| 4 | GOOGL Alphabet Inc. Class A | 2.33M | $803.2M | 3.6% | -11.3% | 13F ↗ |
| 5 | AMZN Amazon.com, Inc. | 2.37M | $593.0M | 2.6% | -8.6% | 13F ↗ |
| 6 | AVGO Broadcom Inc. | 1.64M | $578.5M | 2.6% | -3.0% | 13F ↗ |
| 7 | LLY Eli Lilly and Company | 401,209 | $465.9M | 2.1% | -0.2% | 13F ↗ |
| 8 | MU Micron Technology, Inc. | 421,356 | $450.4M | 2.0% | -0.5% | 13F ↗ |
| 9 | AMD Advanced Micro Devices, Inc. | 684,015 | $420.0M | 1.9% | +3.9% | 13F ↗ |
| 10 | META Meta Platforms, Inc. | 403,580 | $293.7M | 1.3% | +49.1% | 13F ↗ |
| 11 | GOOG Alphabet Inc. Class C | 837,880 | $286.5M | 1.3% | -0.6% | 13F ↗ |
| 12 | TSM Taiwan Semiconductor Manufacturing Company Ltd. | 620,955 | $284.3M | 1.3% | +2.5% | 13F ↗ |
| 13 | TMO Thermo Fisher Scientific Inc | 404,542 | $274.1M | 1.2% | +16.4% | 13F ↗ |
| 14 | PANW Palo Alto Networks, Inc. | 676,466 | $269.7M | 1.2% | -29.8% | 13F ↗ |
| 15 | V Visa Inc. | 679,710 | $245.1M | 1.1% | +5.6% | 13F ↗ |
| 16 | NOW ServiceNow, Inc. | 1.82M | $244.7M | 1.1% | +45.9% | 13F ↗ |
| 17 | LRCX Lam Research Corporation | 713,853 | $235.4M | 1.0% | +0.1% | 13F ↗ |
| 18 | ABBV AbbVie Inc. | 895,789 | $235.2M | 1.0% | -23.1% | 13F ↗ |
| 19 | MRK Merck & Company, Inc. | 1.47M | $214.0M | 1.0% | +3.4% | 13F ↗ |
| 20 | MA Mastercard Incorporated | 381,098 | $210.9M | 0.9% | +0.6% | 13F ↗ |
| 21 | A Agilent Technologies, Inc. | 1.09M | $188.3M | 0.8% | -19.5% | 13F ↗ |
| 22 | GILD Gilead Sciences, Inc. | 1.24M | $185.8M | 0.8% | +4.3% | 13F ↗ |
| 23 | MCK McKesson Corporation | 206,756 | $177.2M | 0.8% | -1.7% | 13F ↗ |
| 24 | CRM Salesforce, Inc. | 765,663 | $176.4M | 0.8% | +53.3% | 13F ↗ |
| 25 | ISRG Intuitive Surgical, Inc. | 428,851 | $175.0M | 0.8% | -0.1% | 13F ↗ |
| 26 | JPM JPMorgan Chase & Co. | 513,198 | $170.4M | 0.8% | -5.7% | 13F ↗ |
| 27 | ADI Analog Devices, Inc. | 384,899 | $153.3M | 0.7% | +29.8% | 13F ↗ |
| 28 | AMGN Amgen Inc. | 352,483 | $149.1M | 0.7% | -2.9% | 13F ↗ |
| 29 | INTC Intel Corporation | 1.20M | $144.8M | 0.6% | +91.2% | 13F ↗ |
| 30 | NEE NextEra Energy, Inc. | 1.88M | $142.9M | 0.6% | -6.3% | 13F ↗ |
| 31 | JNJ Johnson & Johnson | 516,642 | $137.3M | 0.6% | +1.3% | 13F ↗ |
| 32 | KLAC KLA Corporation | 681,613 | $133.4M | 0.6% | -10.4% | 13F ↗ |
| 33 | REGN Regeneron Pharmaceuticals, Inc. | 173,146 | $131.8M | 0.6% | -11.5% | 13F ↗ |
| 34 | HD Home Depot, Inc. | 425,924 | $121.6M | 0.5% | +12.1% | 13F ↗ |
| 35 | UNH UnitedHealth Group Incorporated | 323,073 | $119.0M | 0.5% | +4.5% | 13F ↗ |
| 36 | CRWD CrowdStrike Holdings, Inc. | 440,723 | $117.1M | 0.5% | -22.7% | 13F ↗ |
| 37 | MRVL Marvell Technology, Inc. | 434,204 | $115.1M | 0.5% | -1.7% | 13F ↗ |
| 38 | TSLA Tesla, Inc. | 322,479 | $114.8M | 0.5% | +2.7% | 13F ↗ |
| 39 | ABT Abbott Laboratories | 1.15M | $114.2M | 0.5% | +445% | 13F ↗ |
| 40 | VRTX Vertex Pharmaceuticals Incorporated | 212,933 | $111.7M | 0.5% | +6.7% | 13F ↗ |
| 41 | ONC BeOne Medicines Ltd. · ADR | 289,235 | $106.2M | 0.5% | -0.2% | 13F ↗ |
| 42 | DDOG Datadog, Inc. | 383,724 | $105.5M | 0.5% | +2.1% | 13F ↗ |
| 43 | CDNS Cadence Design Systems, Inc. | 311,375 | $103.2M | 0.5% | +11.7% | 13F ↗ |
| 44 | WDC Western Digital Corporation | 215,886 | $98.5M | 0.4% | -0.2% | 13F ↗ |
| 45 | WAB Westinghouse Air Brake Technologies Corporation | 336,877 | $97.1M | 0.4% | -7.5% | 13F ↗ |
| 46 | BIIB Biogen Inc. | 412,472 | $93.5M | 0.4% | +7.3% | 13F ↗ |
| 47 | RVMD Revolution Medicines, Inc. | 445,693 | $91.8M | 0.4% | -19.9% | 13F ↗ |
| 48 | XYL Xylem Inc. | 875,838 | $89.0M | 0.4% | -10.8% | 13F ↗ |
| 49 | MDB MongoDB, Inc. | 252,296 | $88.3M | 0.4% | -10.1% | 13F ↗ |
| 50 | GEV GE Vernova Inc. | 91,920 | $87.7M | 0.4% | -19.1% | 13F ↗ |
Changes since Q2 2026
23 new, 250 added to, 270 trimmed, 53 exited, 87 unchanged. By estimated dollars.
New positions (23)
| XOM ExxonMobil Holdings Corporation | 370,238 | New | $60.5M |
| ZBIO Zenas BioPharma, Inc. | 654,833 | New | $17.7M |
| SNDK Sandisk Corporation | 9,660 | New | $16.9M |
| GAP Gap, Inc. | 563,583 | New | $12.9M |
| LBRX LB Pharmaceuticals Inc | 284,233 | New | $10.9M |
| BLTE Belite Bio, Inc | 62,842 | New | $10.7M |
| FTH Faeth Therapeutics, Inc. | 319,663 | New | $9.5M |
| ERAS Erasca, Inc. | 492,400 | New | $7.2M |
| OKE ONEOK, Inc. | 75,063 | New | $6.4M |
| BTSG BrightSpring Health Services, Inc. | 99,032 | New | $5.6M |
Added to (250)
| META Meta Platforms, Inc. | 403,580 | +49.1% | $96.7M |
| ABT Abbott Laboratories | 1.15M | +445% | $93.3M |
| NOW ServiceNow, Inc. | 1.82M | +45.9% | $77.0M |
| INTC Intel Corporation | 1.20M | +91.2% | $69.1M |
| CRM Salesforce, Inc. | 765,663 | +53.3% | $61.4M |
| TMO Thermo Fisher Scientific Inc | 404,542 | +16.4% | $38.7M |
| Q Qnity Electronics, Inc. | 342,911 | +641% | $37.4M |
| ADI Analog Devices, Inc. | 384,899 | +29.8% | $35.2M |
| TTWO Take-Two Interactive Software, Inc. | 168,471 | +1568% | $33.0M |
| AMAT Applied Materials, Inc. | 146,209 | +68.0% | $30.4M |
Trimmed (270)
| PANW Palo Alto Networks, Inc. | 676,466 | -29.8% | -$114.3M |
| GOOGL Alphabet Inc. Class A | 2.33M | -11.3% | -$101.8M |
| ABBV AbbVie Inc. | 895,789 | -23.1% | -$70.6M |
| NVDA NVIDIA Corporation | 6.79M | -3.6% | -$57.8M |
| AMZN Amazon.com, Inc. | 2.37M | -8.6% | -$56.1M |
| A Agilent Technologies, Inc. | 1.09M | -19.5% | -$45.6M |
| WELL Welltower Inc. | 105,485 | -64.8% | -$45.0M |
| CRWD CrowdStrike Holdings, Inc. | 440,723 | -22.7% | -$34.4M |
| TNGX Tango Therapeutics, Inc. | 477,921 | -70.7% | -$28.9M |
| AAPL Apple Inc. | 3.55M | -2.4% | -$28.8M |
Exited (53)
| Exxon Mobil Corp | 350,779 | Exited | -$47.9M |
| SNEX StoneX Group Inc. | 584,098 | Exited | -$46.1M |
| RARE Ultragenyx Pharmaceutical Inc. | 1.00M | Exited | -$33.4M |
| Crinetics Pharmaceuticals In | 819,032 | Exited | -$30.6M |
| CRL Charles River Laboratories International, Inc. | 105,152 | Exited | -$23.8M |
| CHE Chemed Corp | 41,398 | Exited | -$19.3M |
| Teva Pharmaceutical Industries Ltd ADR | 550,523 | Exited | -$18.6M |
| Ataibeckley Inc | 3.04M | Exited | -$16.0M |
| LEGN Legend Biotech Corporation · ADR | 504,924 | Exited | -$14.6M |
| PAM Pampa Energia S.A. · ADR | 170,000 | Exited | -$13.9M |
The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.
All positions
Search, sort and filter every position, with puts and calls on their own tab. Premium plan.
Compare two quarters
Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.
Reported value by quarter
Value and number of positions at the end of each quarter.
Loading…
Largest positions in earlier quarters
Pick a quarter to see what the fund's biggest positions were then.
Loading…
Ten largest positions
By value, Q3 2026.
Filings
| Filing | ||||||
|---|---|---|---|---|---|---|
| Q3 2026 | Nov 3, 2026 | 13F-HR | 649 | $22.5B | Current | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | 13F-HR | 678 | $22.2B | Current | SEC ↗ |
| Q1 2026 | Apr 30, 2026 | 13F-HR | 692 | $19.3B | Current | SEC ↗ |
| Q4 2025 | Apr 30, 2026 | 13F-HR/A (restatement) | 685 | $20.1B | Current | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | 13F-HR | 697 | $20.1B | Replaced | SEC ↗ |
| Q3 2025 | Nov 6, 2025 | 13F-HR | 665 | $19.1B | Current | SEC ↗ |
| Q2 2025 | Aug 8, 2025 | 13F-HR | 679 | $17.3B | Current | SEC ↗ |
| Q1 2025 | May 14, 2025 | 13F-HR | 681 | $16.0B | Current | SEC ↗ |
Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer